{"denoms":[{"counts":[{"groupId":"BG000","value":"151"},{"groupId":"BG001","value":"153"},{"groupId":"BG002","value":"304"}],"units":"Participants"}],"groups":[{"description":"etopodide, doxorubicin, cisplatin and mitotane\n\nEtoposide\n\nDoxorubicin\n\nCisplatin\n\nMitotane\n\nparticipants who progressed during first line therapy, were eligible to the alternative treatment (Sz-M)","id":"BG000","title":"EDP-M"},{"description":"streptozotocin and mitotane\n\nStreptozotocin\n\nMitotane\n\nparticipants who progressed during first line therapy, were eligible to the alternative treatment (EDP-M)","id":"BG001","title":"Sz-M"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"151"},{"groupId":"BG001","value":"153"},{"groupId":"BG002","value":"304"}]}],"title":">= 18 years"}],"paramType":"NUMBER","title":"Age, Customized","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"91"},{"groupId":"BG001","value":"92"},{"groupId":"BG002","value":"183"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"60"},{"groupId":"BG001","value":"61"},{"groupId":"BG002","value":"121"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"1"}]}],"title":"III"},{"categories":[{"measurements":[{"groupId":"BG000","value":"151"},{"groupId":"BG001","value":"152"},{"groupId":"BG002","value":"303"}]}],"title":"IV"}],"paramType":"NUMBER","title":"tumor stage","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"73"},{"groupId":"BG001","value":"72"},{"groupId":"BG002","value":"145"}]}],"title":"0"},{"categories":[{"measurements":[{"groupId":"BG000","value":"64"},{"groupId":"BG001","value":"60"},{"groupId":"BG002","value":"124"}]}],"title":"1"},{"categories":[{"measurements":[{"groupId":"BG000","value":"13"},{"groupId":"BG001","value":"21"},{"groupId":"BG002","value":"34"}]}],"title":"2"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"}]}],"title":"4"}],"description":"Eastern Cooperative Oncology Group performance status score (ranges from 0, asymptomatic - 5, dead)","paramType":"NUMBER","title":"ECOG","unitOfMeasure":"participants"}]}